Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
Year: 2002
Type: article
Abstract: AIM: To find an effective symptomatic treatment for osteogenesis imperfecta (OI). METHODS: In a prospective observational study disodium pamidronate (APD) was given as monthly intravenous infusions to 28 children and adolescents (aged 0.6-18 years) with severe OI or a milder form of the disease, but with spinal compression fractures. RESULTS: During treatment for 2-9 years, dual energy x ray absorptiometry measurements of the total body and of the lumbar spine showed a gradual increase in bone density. All bone metabolism variables in serum (alkaline phosphatase, osteocalcin, procollagen 1 C-terminal peptide, collagen 1 teleopeptide) and urine (deoxypyridinoline) indicated that there was a decrease in bone turnover. All patients experienced beneficial effects and the younger patients reported a major improvement in wellbeing, pain, and mobility without significant side effects. Vertebral remodelling was also seen. CONCLUSIONS: APD seems to be an efficient symptomatic treatment for children and adolescents with OI.
Source: Archives of Disease in Childhood
DOI: 10.1136/adc.86.5.356
Authors: E Astrom, S Söderhäll
Institution: Stockholm South General Hospital
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
Funders: Stiftelsen Samariten, Socialstyrelsen
OpenAlex ID: W2107993163
